Moderna has grown revenue −41% a year over three years and −21% a year over five. Revenue growth, 3-year annual rate: −41% (Biotechnology median +21%). Revenue growth, 5-year rate: −21%, growth has slowed since the five-year average. Years of annual history on file: 10, FY2016 to FY2025, as filed.

MRNAModerna

HealthcareUSD

$62.96

$22.3652 weeks$179.79

Is it growing?

Is MRNA growing?

Moderna has grown revenue −41% a year over three years and −21% a year over five.

−41%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −21%
Revenue growth, 5-year rate · −41% over three · growth has slowed since the five-year average
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed

Details›